This company has been acquired
Heska (HSKA) Stock Overview
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
HSKA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Heska Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$119.99 |
| 52 Week High | US$120.03 |
| 52 Week Low | US$57.83 |
| Beta | 1.58 |
| 1 Month Change | 2.58% |
| 3 Month Change | 33.75% |
| 1 Year Change | 39.93% |
| 3 Year Change | 34.49% |
| 5 Year Change | 13.65% |
| Change since IPO | 39.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| HSKA | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.1% | -6.0% | 0.2% |
| 1Y | 39.9% | -21.7% | 19.6% |
Return vs Industry: HSKA exceeded the US Medical Equipment industry which returned 16.3% over the past year.
Return vs Market: HSKA exceeded the US Market which returned 15.1% over the past year.
Price Volatility
| HSKA volatility | |
|---|---|
| HSKA Average Weekly Movement | 6.3% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: HSKA's share price has been volatile over the past 3 months.
Volatility Over Time: HSKA's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 808 | Kevin Wilson | www.heska.com |
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops.
Heska Corporation Fundamentals Summary
| HSKA fundamental statistics | |
|---|---|
| Market cap | US$1.31b |
| Earnings (TTM) | -US$20.03m |
| Revenue (TTM) | US$254.89m |
Is HSKA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HSKA income statement (TTM) | |
|---|---|
| Revenue | US$254.89m |
| Cost of Revenue | US$145.47m |
| Gross Profit | US$109.42m |
| Other Expenses | US$129.45m |
| Earnings | -US$20.03m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.84 |
| Gross Margin | 42.93% |
| Net Profit Margin | -7.86% |
| Debt/Equity Ratio | 22.9% |
How did HSKA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/06/14 22:59 |
| End of Day Share Price | 2023/06/12 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Heska Corporation is covered by 11 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Haynor | Alliance Global Partners |
| Raymond Myers | Benchmark Company |
| Kara Anderson | B. Riley Securities, Inc. |